Concepedia

Author

Shlomzion Aumann

Hadassah Medical Center

Also Known As

Aumann Shlomzion, S. Aumann, S., Aumann, Shlomzion Aumann, Stephanie Mayer

49

Publications

1.1K

Citations

11

H-Index

15

Concepts

All Affiliations

Hadassah Medical CenterHebrew University of JerusalemRambam Health Care CampusTel Aviv UniversityTel Aviv Sourasky Medical Center
SA

About

Shlomzion Aumann is an author at Hadassah Medical Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

578

2

Health Sciences

1

1

20

3

Natural Sciences

1

1

91

4

Cell Biology

1

1

558

5

Molecular Biology

1

1

91

Shlomzion Aumann

×

9

Publications

1K

Citations

9

H-Index

YearCitations

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Eun Hee Kim, Janine O. Ilagan, Yang Liang,

Cancer Cell

2015

558

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease

Jean‐François Emile, Eli L. Diamond, Zofia Hélias‐Rodzewicz,

Blood

2014

242

LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL

Salma Parvin, Ariel Ramírez-Labrada, Shlomzion Aumann,

Cancer Cell

2019

91

COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome

Ilana Levy, Avital Lavi, Eran Zimran,

Leukemia & lymphoma/Leukemia and lymphoma

2021

33

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study

Eyal Lebel, Efstathios Kastritis, Giovanni Palladini,

Cancers

2023

24

Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis

Shai Shimony, Jonathan Canaani, Eitan Kugler,

Annals of Hematology

2022

20

Venetoclax‐based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia

Jonathan Canaani, Avraham Frisch, Daniel A. Pollyea,

European Journal Of Haematology

2023

15

Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights

Boaz Nachmias, Shlomzion Aumann, Arnon Haran,

British Journal of Haematology

2024

14

Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study

Yael Morgenstern, Shlomzion Aumann, Neta Goldschmidt,

Cancer Medicine

2021

11

Page 1